Liposomal‐encapsulated doxorubicin supercharge‐containing front‐line treatment improves response rates in primary mediastinal large B‐cell lymphoma and mediastinal gray zone lymphoma-Reference-Cited by-同舟云学术

Liposomal‐encapsulated doxorubicin supercharge‐containing front‐line treatment improves response rates in primary mediastinal large B‐cell lymphoma and mediastinal gray zone lymphoma

Published:2024-01 Issue:1 Volume:42 Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Picardi Marco¹,Giordano Claudia¹,Pugliese Novella¹,Mascolo Massimo²,Varricchio Silvia²,Troncone Giancarlo³,Vigliar Elena³,Bellavicine Claudio³,Lamagna Martina¹,Lisi Dario¹,Vincenzi Annamaria¹,Pane Fabrizio¹

Affiliation:

1. Department of Clinical Medicine and Surgery Federico II University Medical School Naples Italy

2. Department of Advanced Biomedical Sciences Federico II University Medical School Naples Italy

3. Department of Public Health Federico II University Medical School Naples Naples Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3247

Reference17 articles.

1. DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking

2. Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era

3. Initial clinical (phase I) trial of TLC D‐99 (doxorubicin encapsulated in liposomes);Cowens JW;Cancer Res,1993

4. Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction;Hematological Oncology;2024-04-29